Other health risks When the FDA declared that 19 peptides were not fit for compounding in 2023, the agency largely cited safety risks
This maintenance or recovery of sphincter function by BPC 157 therapy might be contrary to different agents application, (i.e., absolute alcohol, NSAIDs and/or neuroleptics and/or NO-agents, and/or atropine (lower esophageal sphincter, pyloric sphincter, pupil) [107,108,109,110,111,112,113,114,115,117], cyclophosphamide (urinary sphincter) [91], and different (even opposite) dysfunctions, i.e., NOS-blockade, and NOS-over-activity [55,113])
Boost immunity to resist illness
Guevara-CamposJGonzlez-GuevaraLGuevara-GonzlezJCauliO
The logic is compelling - a naturally occurring stomach-protective compound applied to gut healing - but human studies haven't yet validated these effects in real patients with conditions like leaky gut, IBS, or inflammatory bowel disease